Christine Do Cao

5.0k total citations
115 papers, 2.3k citations indexed

About

Christine Do Cao is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Christine Do Cao has authored 115 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Epidemiology and 36 papers in Surgery. Recurrent topics in Christine Do Cao's work include Thyroid Cancer Diagnosis and Treatment (54 papers), Neuroendocrine Tumor Research Advances (35 papers) and Neuroblastoma Research and Treatments (19 papers). Christine Do Cao is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (54 papers), Neuroendocrine Tumor Research Advances (35 papers) and Neuroblastoma Research and Treatments (19 papers). Christine Do Cao collaborates with scholars based in France, United States and Switzerland. Christine Do Cao's co-authors include Éric Baudin, Sophie Leboulleux, Martin Schlumberger, Jean-Louis Wémeau, Marie‐Christine Vantyghem, Bruno Carnaille, Emmanuelle Leteurtre, A.-F. Cailleux, J P Travagli and Philippe Caron and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Christine Do Cao

100 papers receiving 2.3k citations

Peers

Christine Do Cao
Christine Do Cao
Citations per year, relative to Christine Do Cao Christine Do Cao (= 1×) peers Peter Stålberg

Countries citing papers authored by Christine Do Cao

Since Specialization
Citations

This map shows the geographic impact of Christine Do Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Do Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Do Cao more than expected).

Fields of papers citing papers by Christine Do Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Do Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Do Cao. The network helps show where Christine Do Cao may publish in the future.

Co-authorship network of co-authors of Christine Do Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Do Cao. A scholar is included among the top collaborators of Christine Do Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Do Cao. Christine Do Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Christine Do, Niki Christou, Julien Hadoux, & Désirèe Deandreis. (2025). Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor. Annales d Endocrinologie. 86(1). 101697–101697.
2.
Chevalier, Benjamin, Georges Lion, Camille Marciniak, et al.. (2025). Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [18F]FDG PET/CT and131I Posttreatment Scanning. Journal of Nuclear Medicine. 66(2). 330–330.
3.
Jannin, Arnaud, Sophie Dabo‐Niang, Christine Do Cao, et al.. (2025). Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach. European Journal of Endocrinology. 192(4). 466–480.
4.
Cao, Christine Do, Yann Godbert, Stéphane Bardet, et al.. (2025). ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer. Annales d Endocrinologie. 86(4). 101735–101735.
5.
Lasolle, Hélène, Christine Do Cao, Livia Lamartina, et al.. (2025). ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer. Annales d Endocrinologie. 86(4). 101733–101733.
8.
Baudin, Éric, Christine Do Cao, Éric Dansin, et al.. (2023). Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network. Journal of Neuroendocrinology. 35(10). e13331–e13331. 1 indexed citations
9.
Fouchardière, Christelle de la, Johanna Wassermann, Fabien Calcagno, et al.. (2021). Génotypage moléculaire dans les cancers réfractaires de la thyroïde en 2021 : quand, comment, et pourquoi ? Un travail du réseau TUTHYREF. Bulletin du Cancer. 108(11). 1044–1056. 8 indexed citations
10.
Jannin, Arnaud, Livia Lamartina, Georges Lion, et al.. (2020). 1921P Prognostic impact of [18F]FDG-PET/CT in differentiated thyroid cancer with bone metastasis: A French TUTHYREF study. Annals of Oncology. 31. S1089–S1089. 1 indexed citations
11.
Lamartina, Livia, Yann Godbert, Christine Do Cao, et al.. (2020). Locally unresectable differentiated thyroid cancer: outcomes and perspectives. Endocrine. 69(1). 133–141. 12 indexed citations
12.
Jannin, Arnaud, Nicolas Penel, M. Ladsous, Marie‐Christine Vantyghem, & Christine Do Cao. (2019). Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders. Critical Reviews in Oncology/Hematology. 141. 23–35. 48 indexed citations
13.
Aubert, Sébastien, A. Berdelou, Viviane Gnemmi, et al.. (2018). Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(3). 461–468. 28 indexed citations
14.
Wémeau, Jean-Louis, Christine Do Cao, M. Ladsous, & Emmanuelle Leteurtre. (2017). Nodules de la thyroïde : de meilleures quantifications du risque de malignité. Bulletin de l Académie Nationale de Médecine. 201(4-6). 681–697.
16.
Renaud, Florence, Viviane Gnemmi, Patrick Devos, et al.. (2014). MUC1 Expression in Papillary Thyroid Carcinoma Is Associated with BRAF Mutation and Lymph Node Metastasis; the Latter is the Most Important Risk Factor of Relapse. Thyroid. 24(9). 1375–1384. 15 indexed citations
17.
Baudin, Éric, Philippe Caron, Catherine Lombard‐Bohas, et al.. (2013). Malignant insulinoma: Recommendations for characterisation and treatment. Annales d Endocrinologie. 74(5-6). 523–533. 50 indexed citations
18.
Cao, Christine Do, Yibu Chen, Rizwan Masood, Uttam K. Sinha, & Agnieszka Kobielak. (2012). α-Catulin Marks the Invasion Front of Squamous Cell Carcinoma and Is Important for Tumor Cell Metastasis. Molecular Cancer Research. 10(7). 892–903. 22 indexed citations
19.
Wémeau, Jean-Louis & Christine Do Cao. (2008). Cancers anaplasiques de la thyroïde. Annales d Endocrinologie. 69(3). 174–180. 4 indexed citations
20.
Carpentier, P., Christine Do Cao, M. D’Herbomez, et al.. (2007). Thyrotoxicosis revealing metastases of unrecognized thyroid cancer: a report on two cases. Annales d Endocrinologie. 68(5). 389–394. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026